Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/de/ee/42/deee42a1-5c6e-b04f-dcce-4bf28142eb3d/mza_4855141155691672542.png/600x600bb.jpg
Connected With Latham
Latham & Watkins
104 episodes
23 hours ago
In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.
Show more...
Management
Business,
Investing
RSS
All content for Connected With Latham is the property of Latham & Watkins and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.
Show more...
Management
Business,
Investing
Episodes (20/104)
Connected With Latham
Episode 104 – Drug Pricing and Market Access: Deep Dive on the FDA Commissioner's National Priority Voucher Program Awards
23 hours ago
36 minutes 56 seconds

Connected With Latham
Episode 103 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit
1 month ago
19 minutes 53 seconds

Connected With Latham
Episode 102 – EU Data Act: Spotlight on Switching Requirements for Data Processing Services
1 month ago
21 minutes 26 seconds

Connected With Latham
Episode 101 – EU Data Act: Implications for Data Privacy and Cybersecurity
1 month ago
30 minutes 2 seconds

Connected With Latham
Episode 100 – The Leeds Reforms: Implications for UK Financial Services
3 months ago
21 minutes 33 seconds

Connected With Latham
Episode 99 – Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference
4 months ago
22 minutes 56 seconds

Connected With Latham
Episode 98 – Drug Pricing: Takeaways from the MDMA Annual Meeting
5 months ago
40 minutes 21 seconds

Connected With Latham
Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation
6 months ago
50 minutes 18 seconds

Connected With Latham
Episode 96 – The Growth Rocketship: Shield AI's Takeoff Shows What's Possible in Defensetech
6 months ago
52 minutes 23 seconds

Connected With Latham
Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE
7 months ago
22 minutes 14 seconds

Connected With Latham
Episode 94 – Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook
8 months ago
22 minutes 13 seconds

Connected With Latham
Episode 93 – EU's Digital Operational Resilience Act: What You Should Know and How to Stay Compliant
9 months ago
19 minutes 34 seconds

Connected With Latham
Episode 92 – UK FinReg Focus Areas in 2025: Sectoral Trends
10 months ago
29 minutes 45 seconds

Connected With Latham
Episode 91 – UK FinReg Focus Areas in 2025: Retail Markets
10 months ago
20 minutes 32 seconds

Connected With Latham
Episode 90 – UK FinReg Focus Areas in 2025: Wholesale Markets
10 months ago
23 minutes 23 seconds

Connected With Latham
Episode 89 – The Growth Rocketship: How BridgeBio's Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech – Then, Now, and What's Next?
10 months ago
47 minutes 21 seconds

Connected With Latham
Episode 88 – Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?
10 months ago
33 minutes 12 seconds

Connected With Latham
Episode 87 – Drug Pricing: What's In the New CMS Medicaid Final Rule?
11 months ago
28 minutes 38 seconds

Connected With Latham
Episode 86 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit
1 year ago
18 minutes 25 seconds

Connected With Latham
Episode 85 – Drug Pricing: How The Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry
1 year ago
21 minutes 48 seconds

Connected With Latham
In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.